StealTHY: enabling CRISPR-Cas9 screens in immunocompetent hosts to expose concealed metastatic regulators [single-end]
RNA-seq (gene expression) · mouse · 45 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 45 samples: 45 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent modelsCell · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE268044_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1114091 and SRA study SRP508998. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 45 sample titles: 45 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8284812 4T1_CD8_rep1 CD8-transduced 4T1 Mammary fat pad tumor
- GSM8284813 4T1_CD8_rep2 CD8-transduced 4T1 Mammary fat pad tumor
- GSM8284814 4T1_CD8_rep3 CD8-transduced 4T1 Mammary fat pad tumor
- GSM8284815 4T1_KO_rep1 CD8-knockout 4T1 Mammary fat pad tumor
- GSM8284816 4T1_KO_rep2 CD8-knockout 4T1 Mammary fat pad tumor
- GSM8284817 4T1_KO_rep3 CD8-knockout 4T1 Mammary fat pad tumor
- GSM8284818 4T1_UT_rep1 Untransduced 4T1 Mammary fat pad tumor
- GSM8284819 4T1_UT_rep2 Untransduced 4T1 Mammary fat pad tumor
- GSM8284820 4T1_UT_rep3 Untransduced 4T1 Mammary fat pad tumor
- GSM8284821 4T1Cas9BROAD_BLB1 Rejected Cas9-BROAD 4T1 Mammary fat pad tumor
- GSM8284822 4T1Cas9BROAD_BLB2 Rejected Cas9-BROAD 4T1 Mammary fat pad tumor
- GSM8284823 4T1Cas9BROAD_BLB3 Rejected Cas9-BROAD 4T1 Mammary fat pad tumor
- GSM8284824 4T1NSG1 Rejection control 4T1 Mammary fat pad tumor
- GSM8284825 4T1NSG2 Rejection control 4T1 Mammary fat pad tumor
- GSM8284826 4T1NSG3 Rejection control 4T1 Mammary fat pad tumor
- GSM8284827 MVT1_CD8_rep1 CD8-transduced MVT1 Mammary fat pad tumor
- GSM8284828 MVT1_CD8_rep2 CD8-transduced MVT1 Mammary fat pad tumor
- GSM8284829 MVT1_CD8_rep3 CD8-transduced MVT1 Mammary fat pad tumor
- GSM8284830 MVT1_KO_rep1 CD8-knockout MVT1 Mammary fat pad tumor
- GSM8284831 MVT1_KO_rep2 CD8-knockout MVT1 Mammary fat pad tumor
- GSM8284832 MVT1_KO_rep3 CD8-knockout MVT1 Mammary fat pad tumor
- GSM8284833 MVT1_UT_rep1 Untransduced MVT1 Mammary fat pad tumor
- GSM8284834 MVT1_UT_rep2 Untransduced MVT1 Mammary fat pad tumor
- GSM8284835 MVT1_UT_rep3 Untransduced MVT1 Mammary fat pad tumor
- GSM8284836 MVT1NSG1 Rejection control MVT1 Mammary fat pad tumor
- GSM8284837 MVT1NSG2 Rejection control MVT1 Mammary fat pad tumor
- GSM8284838 MVT1NSG3 Rejection control MVT1 Mammary fat pad tumor
- GSM8284839 MVTCas9BROAD_FVB1 Rejected Cas9-BROAD MVT1 Mammary fat pad tumor
- GSM8284840 MVTCas9BROAD_FVB2 Rejected Cas9-BROAD MVT1 Mammary fat pad tumor
- GSM8284841 MVTCas9BROAD_FVB3 Rejected Cas9-BROAD MVT1 Mammary fat pad tumor
- GSM8284842 Py2T_CD8_rep1 CD8-transduced Py2T Mammary fat pad tumor
- GSM8284843 Py2T_CD8_rep2 CD8-transduced Py2T Mammary fat pad tumor
- GSM8284844 Py2T_CD8_rep3 CD8-transduced Py2T Mammary fat pad tumor
- GSM8284845 Py2T_KO_rep1 CD8-knockout Py2T Mammary fat pad tumor
- GSM8284846 Py2T_KO_rep2 CD8-knockout Py2T Mammary fat pad tumor
- GSM8284847 Py2T_KO_rep3 CD8-knockout Py2T Mammary fat pad tumor
- GSM8284848 Py2T_UT_rep1 Untransduced Py2T Mammary fat pad tumor
- GSM8284849 Py2T_UT_rep2 Untransduced Py2T Mammary fat pad tumor
- GSM8284850 Py2T_UT_rep3 Untransduced Py2T Mammary fat pad tumor
- GSM8284851 Py2TNSG1 Rejection control Py2T Mammary fat pad tumor
+ 5 more — browse all 45 samples with per-sample file links →
- GSE268045 StealTHY: enabling CRISPR-Cas9 screens in immunocompetent hosts to expose concealed metastatic regulators [paired-end] 70 samples shares immunocompetent, crispr-cas9, metastatic, regulators, concealed, stealthy, enabling
- GSE199855 shRNA-mediated silencing of candidate pluripotency regulators in mouse epibladst stem cells 798 samples shares regulators
- GSE264086 Understanding and reversing mammary tumour-driven reprogramming of myelopoieisis to reduce metastatic spread [bulk RNA-seq] 100 samples shares metastatic
- GSE334845 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors [RNA-Seq] 86 samples shares regulators
- GSE302682 Sleeping Beauty mutagenesis identifies BACH2 and other regulators promoting CD8+ T cell persistence and effector function under tumor-associated chronic antigen stimulation - RNAseq 66 samples shares regulators
- GSE312282 In vivo CRISPR screening identifies SAGA complex members as a key regulators of hematopoiesis [RNA] 56 samples shares regulators
- GSE301299 Multi-omics analysis identifies intrinsic Trp53 driven metastatic breast cancer subtypes [RNA-seq] 51 samples shares metastatic
- GSE306627 TGFβ signaling in cancer-associated fibroblasts drives a hepatic gp130-dependent pro-metastatic inflammatory program in colorectal cancer 42 samples shares metastatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.